医学
阿柏西普
黄斑变性
眼科
视网膜静脉
视力
黄斑水肿
糖尿病性视网膜病变
德鲁森
视网膜
糖尿病
新生血管性青光眼
小梁切除术
血管抑制剂
视网膜分支静脉阻塞
前瞻性队列研究
青光眼
外科
闭塞
教学医院
视网膜病变
验光服务
疾病
眼压
作者
Goulé AM,Konan Virgile Koffi,Zana Diabaté,Gosse François Diomandé,Bilé PEFK,Konan MP,Godé LE,Babayeju RLO,Koffi KAP,Coulibaly KA,Yves Ouattara,Diomandé IA
标识
DOI:10.33425/2639-9482.1053
摘要
Introduction: Intravitreal anti-vascular endothelial growth factor (anti-VEGF) injections have become a cornerstone in the management of neovascular and exudative retinal and choroidal pathologies. This study aimed to determine the indications and demographic patterns associated with intravitreal aflibercept injections at the Teaching Hospital of Bouake. Patients and Methods: A prospective descriptive study was conducted from August 1, 2023, to March 1, 2025, at the Teaching Hospital of Bouake. The study included 40 patients who received intravitreal aflibercept injections during this period. Data collected included sociodemographic characteristics, ocular history, clinical findings, visual acuity, and indications for injection. Results: A total of 40 patients were included, with a mean age of 54.65 years (range: 30–76 years). Males predominated with a sex ratio of 2.07. Civil servants and traders accounted for 32.5% (n=13) and 30% (n=12), respectively. The most common comorbidities were diabetes mellitus (45%, n=18) and primary open-angle glaucoma (30%, n=12). Injections were administered unilaterally in 87.5% (n=35), predominantly in the left eye (52.5%, n=21). Uncorrected distance visual acuity before injection ranged from hand motion to counting fingers in 45% (n=18). Clinical signs included retinal hemorrhages (40%, n=16) and drusen (20%, n=8). The main indication for intravitreal aflibercept was diabetic macular edema (DME) in 45% (n=18), followed by macular edema secondary to retinal vein occlusion (RVO) in 22.5% (n=9), and age-related macular degeneration (AMD) in 20% (n=8). Conclusion: Intravitreal anti-VEGF therapy remains an effective therapeutic modality for managing neovascular and exudative retinal diseases. Our findings reflect the growing burden of diabetic eye disease and vascular pathologies in our setting.
科研通智能强力驱动
Strongly Powered by AbleSci AI